Skip to main content

Day: October 27, 2025

L.B. Foster Company to Report Third Quarter 2025 Results on November 3, 2025

PITTSBURGH, Oct. 27, 2025 (GLOBE NEWSWIRE) — L.B. Foster Company (Nasdaq: FSTR, the “Company”), today announced that it will release its third quarter results, pre-market opening on Monday, November 3, 2025. L.B. Foster will host a conference call to discuss its operating results, market outlook, and developments in the business that morning at 8:30 A.M. Eastern Time. A presentation will be available on the Company’s website under the Investor Relations page immediately after the Company’s earnings release. The conference call will be webcasted live through L.B. Foster’s Investor Relations page of the Company’s website (www.lbfoster.com). The webcast is listen-only. A webcast replay will be available through November 10, 2025, on L.B. Foster’s Investor Relations page. Those interested in participating in the question-and-answer...

Continue reading

Gray Media Names Nick Hasenecz as General Manager of WNDU in South Bend, Indiana

ATLANTA, Oct. 27, 2025 (GLOBE NEWSWIRE) —  Gray Media announced today the promotion of Nick Hasenecz to General Manager of WNDU, the NBC affiliate in South Bend, Indiana, serving the South Bend – Elkhart market, effective December 1, 2025.                Nick is a veteran broadcast television executive with more than 30 years of experience leading high-performing teams, growing revenue, and driving innovation across multiple markets. He currently serves as Director of Sales and Interim General Manager for WOIO, WUAB, and Telemundo Cleveland, where his leadership has guided the stations to record-breaking new business results in 2024 and 2025.         Nick began his career in research at TELEREP before becoming Research Director at WAVY-TV 10 in Norfolk, Virginia. His analytical expertise and deep understanding of audience...

Continue reading

Vastned remains on track to achieve its stated objectives

✔ Fair value of real estate portfolio increases by € 26.4 million (+ 2.1% compared to 31 December 2024 – pro forma). ✔ The occupancy rate of 98.6% remains at a stable and high level.✔ EPRA earnings of € 1.67 per share for the first nine (9) months of 2025.✔ The debt ratio (EPRA LTV) is 39.9%, compared to 42.5% per 31 December 2024 (pro forma). This implies that Vastned achieved its target of an EPRA LTV below 40.0%. ✔ The past months, Vastned has continued to work on realizing the targeted synergies. By closely monitoring costs, Vastned can further increase its forecast for the EPRA earnings per share from € 2.00 – € 2.10 to € 2.10 – € 2.20. ✔ Due to the increase in the expected EPRA earnings per share, Vastned’s board of directors is raising the dividend outlook from € 1.70 to € 1.80 gross per...

Continue reading

Hapbee Appoints New Leaders to Accelerate Women’s Wellness Through Frequency Healing Technology

Expanding focus into FemTech positions Hapbee to scale across a USD 177 billion market by uniting neuroscience, sleep optimization, and women-led innovation VANCOUVER, British Columbia, Oct. 27, 2025 (GLOBE NEWSWIRE) — Hapbee Technologies Inc. (“Hapbee” or the “Company”) (TSXV: HAPB | OTCQB: HAPBF | FWB: HA1) — Hapbee Technologies Inc. (“Hapbee”), the pioneer in frequency-based digital wellness technology, today announced the appointment of Jodie Jackson as Chief Neural Optimization Officer and Nancy H. Rothstein as Chief Sleep Officer. These additions mark a defining moment for Hapbee’s evolution as the company deepens its commitment to women’s wellness – a sector rapidly transforming the global health landscape. The initiative aligns with Hapbee’s long-term growth strategy to scale its proprietary frequency-based platform...

Continue reading

Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences

Saint-Herblain (France), October 27, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in 1-on-1 meetings with institutional investors at upcoming investor conferences in the United States and Europe.  Valneva will host moderated “fireside chat” presentations to discuss the Company’s key value drivers and upcoming catalysts, primarily the upcoming Phase 3 trial outcomes for VLA15, the Company’s Lyme disease vaccine candidate, which is partnered with Pfizer. If successful, Pfizer aims to submit applications for U.S. and European market authorization in 2026. Pending approval, Valneva expects Pfizer to launch the vaccine in the second half of 2027.  Guggenheim 2nd Annual Healthcare Innovation Conference Date/Time: November 10, 10:30am...

Continue reading

Participation notification by Morgan Stanley

Press release                                                                  Regulated information Brussels, October 27, 2025, 17:45 CET In line with Belgian transparency legislation (Law of May 2, 2007), Morgan Stanley recently sent to Solvay the following transparency notification indicating that they crossed the threshold of 3%.  Here is a summary of the notification:Date on which the threshold was crossed Voting rights after the transaction Equivalent financial instruments after the transaction TotalOctober 16, 2025 / / /The notification, dated October 22, 2025, contains the following information:Reason for the notification: Acquisition or disposal of financial instruments that are treated as voting securities Downward crossing of the lowest thresholdNotified by: A parent undertaking or a controlling...

Continue reading

Matmut Group – First-Half 2025 Revenues up 16.7%

Press release First-Half 2025 Revenues up 16.7%Earned premiums: €1,8231 million, up 16.7% Strong contribution from Savings and Protection activities Total contracts: 8.4 million, +1.3% Ongoing enhancement of the P & C portfolio qualityCommenting on the Group’s performance for the first half of 2025, Nicolas Gomart, Vice-Chairman and Chief Executive Officer of Matmut Group, stated: “Matmut Group continues to implement its strategic plan Objectif: Impact! 2024-2026. Our goal of strategic diversification should materialize soon with the upcoming completion of the acquisition of HSBC Assurances Vie (France)2.Let us recall that the Group strengthened its financial position in May 2025 with the successful completion of its inaugural subordinated debt issue of €500 million, intended to finance part of the acquisition of HSBC Assurances...

Continue reading

Sidetrade Completes Acquisition of ezyCollect

Sidetrade, a global leader in AI-powered Order-to-Cash applications, today announced the completion of the acquisition of 100% of ezyCollect, a leading Australian SaaS provider specializing in Order-to-Cash solutions for small and mid-sized businesses. Announced on October 13, 2025 (cf. press release), the transaction marks another milestone in Sidetrade’s international growth strategy. Already established in Europe and North America, Sidetrade is now expanding its footprint into Asia-Pacific. The addition of ezyCollect provides the Group with a new growth engine in a highly dynamic, fast-growing market. The transaction values ezyCollect at €37.3 million (A$66.5 million), including €34.7 million (A$61.9 million) paid in cash at closing and €2.6 million (A$4.6 million) in Sidetrade free shares, designed to retain the company’s two founders...

Continue reading

Gray Media Names Chris Conroy as General Manager of WOIO, WUAB, and WTCL in Cleveland, Ohio

      ATLANTA, Oct. 27, 2025 (GLOBE NEWSWIRE) — Gray Media, Inc. has named Chris Conroy as the next General Manager of WOIO (CBS), WUAB (CW), and WTCL (Telemundo) in Cleveland, Ohio.                Chris brings four decades of extensive media leadership experience to the role. He most recently served as General Manager of Gray’s KFVS in Cape Girardeau, MO, a position he has held since 2018. During his tenure, KFVS enhanced its status as the top-rated station in its market, earning the prestigious Edward R. Murrow Regional Award for Overall Excellence in 2020. He was instrumental in ratings growth and significant year-over-year increases in digital impressions and audience engagement.         Prior to his role at KFVS, Chris was the General Manager at Gray’s KAIT in Jonesboro, AR, where he successfully launched the market’s NBC...

Continue reading

Smith+Nephew comparative study1 shows  PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure wound therapy (sNPWT) devices in orthopedic and cardiovascular surgery. Analyzing real-world data from over 22,000 patients in the Premier PINC AI™ Healthcare Database, the analysis reveals that prophylactic use of PICO sNPWT (-80 mmHg) significantly reduces the risk of wound dehiscence, hospital length of stay (LoS), and overall healthcare costs compared to the PrevenaTM -125 mmHg sNPWT device.Smith + Nephew’s PICO Single Use Negative Pressure Wound Therapy System An estimated 313 million surgical procedures are performed worldwide each year, with the number continuing to rise.2 In the United States, surgical site infections (SSIs) occur...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.